Salvianolic acid A inhibits tumor-associated angiogenesis by blocking GRP78 secretion
- 60 Downloads
Glucose-regulated protein 78 (GRP78) often highly expresses in a wide range of tumors, which plays promotive functions due to its diversity of location in the development of tumor. Particularly, GRP78 can be secreted into microenvironment by tumor cells through the pathway of exosome, which promotes proliferation, angiogenesis, and drug resistance in cancer cells. Hence, we discovered a potential inhibitor to block GRP78 secretion. We screened five small molecules that may interact with the GRP78 from 51 traditional Chinese medicine molecules by molecular docking. By using western blot, we found that one of the molecules can inhibit the secretion of GRP78, which is salvianolic acid A (SAA). Further, SAA could interact with the lysine residue 633 (K633) of GRP78, which inhibited GRP78 secretion. Moreover, SAA-GRP78 interaction can facilitate GRP78 of cytosol sorted into lysosome for degradation rather than exosome. In conclusion, our research revealed that SAA has the novel function of anti-angiogenesis via the tumor environment.
KeywordsTumor-secreted GRP78 Salvianolic acid A Exosome Interaction Angiogenesis
Salvianolic acid A
Glucose-regulated protein 78
Lysine residue 633
Epidermal growth factor receptor
Vascular endothelial growth factor
ZL and LZ conceived and designed research. YY conducted experiments. HL and SG contributed new reagents or analytical tools. XL analyzed data. YY wrote the manuscript. All authors read and approved the manuscript.
This work was financially supported by the National Natural Science Foundation of China [No. 31770382], National Natural Science Foundation of China [No. 81803791], Shanxi Province Science Foundation for Youths [201601D021108], and “1331 Project” Collaborative Innovation Center [1331 CIC].
Compliance with ethical standards
All of the mouse experiments were approved by the Institutional Animal Care and Use Committee of Shanxi University (Taiyuan, China). All of the experimental procedures were performed in accordance with the protocols and ethical regulations approved by the Institutional Animal Care and Use Committee of Shanxi University (Taiyuan, China).
Conflict of interest
The authors declare that they have no conflicts of interest.
- Dong D, Ni M, Li J, Xiong S, Ye W, Virrey JJ, Mao C, Ye R, Wang M, Pen L, Dubeau L, Groshen S, Hofman FM, Lee AS (2008) Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development. Cancer Res 68:498–505. https://doi.org/10.1158/0008-5472.CAN-07-2950 CrossRefPubMedGoogle Scholar
- Dong D, Stapleton C, Luo B, Xiong S, Ye W, Zhang Y, Jhaveri N, Zhu G, Ye R, Liu Z, Bruhn KW, Craft N, Groshen S, Hofman FM, Lee AS (2011) A critical role for GRP78/BiP in the tumor microenvironment for neovascularization during tumor growth and metastasis. Cancer Res 71:2848–2857. https://doi.org/10.1158/0008-5472.CAN-10-3151 CrossRefPubMedPubMedCentralGoogle Scholar
- Gorbatyuk MS, Gorbatyuk OS (2013) The molecular chaperone GRP78/BiP as a therapeutic target for neurodegenerative disorders: a mini review. J Genet Syndr Gene Ther 4. https://doi.org/10.4172/2157-7412.1000128
- Mehdiani A, Maier A, Pinto A, Barth M, Akhyari P, Lichtenberg A (2015) An innovative method for exosome quantification and size measurement. J Vis Exp:50974. https://doi.org/10.3791/50974
- Peinado H, Alečković M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, García-Santos G, Ghajar CM, Nitadori-Hoshino A, Hoffman C, Badal K, Garcia BA, Callahan MK, Yuan J, Martins VR, Skog J, Kaplan RN, Brady MS, Wolchok JD, Chapman PB, Kang Y, Bromberg J, Lyden D (2012) Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 18:883–891. https://doi.org/10.1038/nm.2753 CrossRefPubMedPubMedCentralGoogle Scholar
- Ruggiero C, Doghman-Bouguerra M, Ronco C, Benhida R, Rocchi S, Lalli E (2018) The GRP78/BiP inhibitor HA15 synergizes with mitotane action against adrenocortical carcinoma cells through convergent activation of ER stress pathways. Mol Cell Endocrinol 474:57–64. https://doi.org/10.1016/j.mce.2018.02.010 CrossRefPubMedGoogle Scholar
- Sundberg C, Nagy JA, Brown LF, Feng D, Eckelhoefer IA, Manseau EJ, Dvorak AM, Dvorak HF (2001) Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery. Am J Pathol 158:1145–1160. https://doi.org/10.1016/S0002-9440(10)64062-X CrossRefPubMedPubMedCentralGoogle Scholar
- Zhang Q, Wang S, Yu Y, Sun S, Zhang Y, Zhang Y, Yang W, Li S, Qiao Y (2016) Salvianolic acid a, as a novel ETA receptor antagonist, shows inhibitory effects on tumor in vitro. Int J Mol Sci 17. https://doi.org/10.3390/ijms17081244
- Zheng X, Chen S, Yang Q, Cai J, Zhang W, You H, Xing J, Dong Y (2015) Salvianolic acid A reverses the paclitaxel resistance and inhibits the migration and invasion abilities of human breast cancer cells by inactivating transgelin 2. Cancer Biol Ther 16:1407–1414. https://doi.org/10.1080/15384047.2015.1070990 CrossRefPubMedPubMedCentralGoogle Scholar